NDC 13913-012-01 - Cambia
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13913-012
- Requested NDC
- 13913-012-01
- Package NDCs from labels
- 13913-012-01, 13913-012-03, 13913-012-02
- Manufacturer
- Assertio Therapeutics, Inc.
- Effective date
- 2024-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cambia - Assertio Therapeutics, Inc. | Assertio Therapeutics, Inc. | 2024-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13913-012-01 | Cambia | 1 in 1 PACKET | POWDER, FOR SOLUTION | 1 | 9 | |
| 13913-012-02 | Cambia | 1 in 1 PACKET | POWDER, FOR SOLUTION | 1 | 9 | |
| 13913-012-02 | Cambia | 9 in 1 CARTON | POWDER, FOR SOLUTION | 9 | 9 | |
| 13913-012-03 | Cambia | 9 in 1 CARTON | POWDER, FOR SOLUTION | 9 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13913-012-01 | EA - Each | 13913-012 | a4afaf38-fa08-4e82-ae9a-1cfd685736fb | 1 | 2016-11-08 |
| 13913-012-03 | EA - Each | 13913-012 | c3596580-b003-4c2f-aa16-8cf4a3bbad33 | 1 | 2016-11-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Potassium | DICLOFENAC POTASSIUM | SOLA Pharmaceuticals, LLC | e770efc8-bbad-4103-98e4-e31019a540f5 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Northwind Health Company, LLC | f2b6a4dd-e4e2-4acc-e053-2995a90aebf2 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM | Nivagen Pharmaceuticals, Inc. | eb52a015-23cd-40f6-bf83-6749fc34947c | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 859063 L4D5UA6CB4 |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM, FILM COATED | INA Pharmaceutics Inc, | 6c703075-b9a3-42de-87f6-fd1e1ef4b2e3 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Chartwell RX, LLC | 3a837a3e-10b2-4256-b515-80c863318ccb | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM TABLETS | NIVAGEN PHARMACEUTICALS, INC. | 1f06a404-07c3-4414-8c5c-357c01d6ccb3 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | SOLA Pharmaceuticals, LLC | 26bf3a4a-42c6-cb59-e063-6394a90abd8b | 2025-12-08 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | HM5Z15LEBN |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Doc Rx | 6394ab5f-b3ff-4397-97eb-ff92485c5ec0 | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Phoenix RX LLC | 3fd418ac-49f6-d520-e063-6394a90afbd8 | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Ingenus Pharmaceuticals, LLC | 6926444f-0dca-4aeb-812e-755a83b149f4 | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM, FILM COATED | Golden State Medical Supply, Inc. | 26d0ed73-b7a6-cbd8-e063-6394a90a9a31 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Trifluent Pharma LLC | 8fdb1036-c0d8-4288-ac37-6512b05672ef | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM, FILM COATED | Happy Robin, LLC | 3f91023f-9db9-88ba-e063-6394a90abd44 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | INA Pharmaceutics Inc | 5ecd99fe-cb74-4a65-9636-2aefd2416ece | 2025-10-06 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.